Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2023, Alnylam Pharmaceuticals (ALNY) reported revenue of $439.72 million, up 31.2$1.10, compared to -$1.68 in the year-ago quarter.The reported revenue represents a surprise of -1.31$445.57 million. With the consensus EPS estimate being -$1.20, the EPS surprise was +8.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compar ...